Experience

Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million aggregate principal amount of 2.75% convertible senior notes due…

Davis Polk advised the joint book-running managers on an SEC-registered offering of $400 million aggregate principal amount of 3.75% senior notes due 2046. Headquartered in Lake…

Davis Polk advised the representatives of the underwriters, in connection with an SEC-registered offering by AbbVie Inc. (“AbbVie”) of $7.8 billion aggregate principal amount of senior…

Davis Polk advised the joint book-running managers in connection with an SEC-registered common stock offering of 45,000,000 shares of common stock of Synergy Resources Corporation. The…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Knowles Corporation of $150 million aggregate principal amount of its 3.25%…

Davis Polk advised the joint book-running managers in connection with an SEC-registered common stock offering of 22,425,000 shares of common stock of Synergy Resources Corporation. Included…

Davis Polk is advising Markit on its all-share merger of equals with IHS valued at more than $13 billion. The transaction is expected to close in the second half of 2016, subject to…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Fluor Corporation of €500 million aggregate…

Davis Polk advised the joint book-running managers on an SEC-registered offering by KKR & Co. L.P. of 13,800,000 6.75% Series A preferred units, which includes the full exercise of the…

Davis Polk advised the dealer managers in connection with a Rule 144A/Regulation S exchange offer by Cliffs Natural Resources Inc. of approximately $218 million of new 8.0% 1.5 lien senior…